"Candidiasis, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)
| Descriptor ID |
D002180
|
| MeSH Number(s) |
C01.703.160.180 C07.465.130
|
| Concept/Terms |
Candidiasis, Oral- Candidiasis, Oral
- Candidiases, Oral
- Oral Candidiases
- Oral Candidiasis
- Thrush
- Moniliasis, Oral
- Moniliases, Oral
- Oral Moniliases
- Oral Moniliasis
|
Below are MeSH descriptors whose meaning is more general than "Candidiasis, Oral".
Below are MeSH descriptors whose meaning is more specific than "Candidiasis, Oral".
This graph shows the total number of publications written about "Candidiasis, Oral" by people in this website by year, and whether "Candidiasis, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Candidiasis, Oral" by people in Profiles.
-
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials. Br J Dermatol. 2024 03 15; 190(4):477-485.
-
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials. JAMA Dermatol. 2022 07 01; 158(7):735-744.
-
Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. AIDS. 2017 01 02; 31(1):81-88.
-
Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC Oral Health. 2012 Jul 20; 12:22.